期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

以叶酸受体为靶向的脂质体介导MYCN基因小干扰RNA体外抑制神经母细胞瘤LA-N-5细胞的增殖 被引量：1

In vitro inhibition of LA-N-5 cell growth by folate receptor-targeted liposome-induced MYCN gene siRNA inhibits
原文传递
导出
摘要 目的以氨基脂为主要成分、叶酸受体为靶向的脂质体包裹MYCN基因小干扰性RNA,研究其体外对神经母细胞瘤LA-N-5细胞MYCN基因表达的抑制及细胞增殖的影响。方法制备氨基脂为主要成分、叶酸受体为靶向的脂质体包裹CY3标记的MYCNsiRNA转染LA-N-5细胞,以每微克蛋白中荧光强度半定量siRNA的转染效果;用定量RT-PCR检测转染前后MYCN基因mRNA变化;MTT法检测细胞增殖受抑情况。结果以100nmol/L终浓度转染LA-N-5细胞后每微克蛋白含siRNA(1808.5±140.2)pg,作用72hMYCN基因mRNA表达显著下降,抑制率79.2%,瘤细胞增殖受抑达66.2%。结论叶酸受体为靶向脂质体介导MYCNsiRNA在体外对LA-N-5细胞MYCNmRNA表达有显著抑制作用,明显抑制LA-N-5细胞增殖,为神经母细胞瘤靶向治疗、基因治疗开辟了新的思路。 Objective To study the inhibitory effect of folate receptor-targeted MYCN gene siRNA on the expression and growth of LA-N-5 cells. Methods LA-N-5 cells were transfected with MYCN siRNA marked by folate receptor-targeted liposome-induced Cy3. The transfected siRNA was expressed as fluorescence intensity per μg protein. Changes in MYCN mRNA before and after transfection were detected by real-time quantitative PCR （RT-PCR）. Inhibition of LA-N-5 cell growth was assayed by MTT. Results Perμg protein contained （1 808.5 ± 140.2）pg siRNA in LA-N-5 ceils transfected with 100nmol/L MYCN siRNA. The inhibion rate of MYCN mRNA expression and LA-N-5 cell growth was 79.2% and 66.2%, respectively, 72 hours after transfection. Conclusion Folate receptor-targeted liposome-induced MYCN siRNA can significantly inhibit the expression of MYCN mRNA in LA-N-5 cells and the growth of LA-N-5 cells in vitro,which may open up a new way to the gene and target therapy for neuroblastoma.
作者 冯晨 唐锁勤 王建文 龙卉 杨光
机构地区 解放军总医院小儿内科
出处 《军医进修学院学报》 CAS 2010年第2期161-163,共3页 Academic Journal of Pla Postgraduate Medical School
基金 国家自然科学基金项目( 30471802)~~
关键词 神经母细胞瘤 MYCN基因 RNA 小分子干扰 叶酸 Neuroblastoma MYCN Gene RNA, Small Interfeering Folic Acid
分类号 R730.264 [医药卫生—肿瘤] R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献7

  • 1Kraveka JM, Li L, Bielawski J, et al. Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells [ J ] . Arch Biochem Biophys, 2003, 419 (2): 110-119.
  • 2Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuro- blastomas [J] .N Engl J Med, 1985, 313 (18): 1111-1116.
  • 3Sioud M. Therapeutic siRNAs [ J ] . Trends Pharmacol Sci, 2004, 25 ( 1 ) : 22-28.
  • 4Pan XQ, Zheng X, Shi G, et al. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using alltrans retinoic acid [ J ] . Blood, 2002, 100 ( 2 ) : 594-602.
  • 5冯晨,唐锁勤,张晓飞,王建文,龙卉,高晓宁.RNA干扰抑制神经母细胞瘤细胞MYCN基因的初步研究[J].临床儿科杂志,2006,24(2):95-97. 被引量：2
  • 6Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21- nueleotide RNAs mediate RNA interference in cultured mammalian cells [J].Nature, 2001, 411:494-498.
  • 7Scherr M, Battmer K, Winkler T, et al. Specific inhibition of bcr- abl gene expression by small interfering RNA [ J ] . Blood, 2003, 101 ( 4 ) : 1566-1569.

二级参考文献11

  • 1唐锁勤,张晓飞,黄东生,王建文,刘立真,于芳,徐莹.以CDV和CiE持续静脉滴注为诱导方案治疗晚期神经母细胞瘤[J].临床儿科杂志,2004,22(9):614-616. 被引量：5
  • 2Kraveka JM,Li L,Bielawski J,et al.Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells.Arch Biochem Biophys,2003,419(2):110-119.
  • 3Seeger RC,Brodeur GM,Sather H,et al.Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.N Engl J Med,1985,313(18):1111-1116.
  • 4Sioud M.Therapeutic siRNAs.Trends Pharmacol Sci,2004,25(1):22-28.
  • 5Nakagawara A,Ikeda K,TsudaT,et al.N-myc oncogene amplification and prognostic factors of neuroblastoma in children.J Pediatr Surg,1987,22:895-898.
  • 6Galderisi U,Bernardo GD,Cipollaro M,et al.Differentiation and apoptosis of neuroblastoma cells:role of N-myc gene product.J Cell Biochem,1999,73:97-105.
  • 7Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature,2001,411:494-498.
  • 8Scherr M,Batnards R,Winkler T,et al.Specific inhibition of bcr-abl gene expression by small interfering RNA.Blood,2003,101(4):1566-1569.
  • 9Felgner PL,Gadek TR,Holm M,et al.Lipofection:a highly efficient,lipid-mediated DNA-transfection procedure.Proc Natl Acad Sci USA,1987,84(21):7413-7417.
  • 10Pan XQ,Zheng X,Shi G,et al.Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.Blood,2002,100(2):594-602.

共引文献1

同被引文献7

  • 1Pearson A,Lunec J. The MYCN oncoprotein as a drug development target [J]. Cancer Lett, 1997, (3) :125-130.
  • 2Nara K,Kusafuka T,Yoneda A,et al. Silencing of MYCN by RNA interference induces growth inhibition,apoptotic activity and cell differentia- tion in a neuroblastoma cell line with MYCN amplification [J]. Int J Oncol ,2007,30(5) : 1189-1196.
  • 3Huang Y,Hong J,Zheng S,et al. Elimination pathways of systemically delivered siRNA [J]. Mol Ther,2011,19(2) :381-385.
  • 4Birmingham A,Anderson EM,Reynolds A,et al. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets[J]. Nat Methods, 2006,3 : 199-204.
  • 5Stevens PJ,Sekido M ,Lee RJ. A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug [J]. Pharm Res, 2004,21 (12) :2153-2157.
  • 6Daldrup HE,Hawkins RA,Meier R,et al. Receptor imaging of pediatric tumors: clinical practice and new developments [J]. Pediatr Radiol, 2008,38(11): 1154-1161.
  • 7Pan X, Lee RJ. Tumour-selective drug delivery via folate receptor-targeted liposomes [J]. Expert Opin Drug Deliv,2004,1 ( 1 ) :7-17.

引证文献1

二级引证文献1

军医进修学院学报
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部